Bessemer Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.1M | Buy |
220,296
+48,458
| +28% | +$4.97M | 0.03% | 290 |
|
|
2026
Q1 | $18.8M | Buy |
171,838
+128,033
| +292% | +$12.2M | 0.03% | 289 |
|
|
2025
Q4 | $3.55M | Buy |
43,805
+37,324
| +576% | +$3.21M | 0.01% | 534 |
|
|
2025
Q3 | $568K | Buy |
6,481
+529
| +9% | +$47.2K | ﹤0.01% | 815 |
|
|
2025
Q2 | $494K | Sell |
5,952
-158
| -3% | -$13.2K | ﹤0.01% | 823 |
|
|
2025
Q1 | $513K | Buy |
6,110
+59
| +1% | +$5.49K | ﹤0.01% | 869 |
|
|
2024
Q4 | $557K | Buy |
6,051
+11
| +0.2% | +$1.06K | ﹤0.01% | 860 |
|
|
2024
Q3 | $561K | Sell |
6,040
-30
| -0.5% | -$2.6K | ﹤0.01% | 870 |
|
|
2024
Q2 | $499K | Sell |
6,070
-1,046
| -15% | -$76.8K | ﹤0.01% | 799 |
|
|
2024
Q1 | $472K | Sell |
7,116
-849
| -11% | -$52.4K | ﹤0.01% | 822 |
|
|
2023
Q4 | $452K | Buy |
7,965
+655
| +9% | +$34.3K | ﹤0.01% | 853 |
|
|
2023
Q3 | $398K | Buy |
7,310
+98
| +1% | +$5.81K | ﹤0.01% | 871 |
|
|
2023
Q2 | $485K | Buy |
+7,212
| New | +$440K | ﹤0.01% | 826 |
|
|
2022
Q4 | – | Sell |
-266
| Closed | -$13K | – | 2045 |
|
|
2022
Q3 | $13K | Buy |
+266
| New | +$13.3K | ﹤0.01% | 1487 |
|
|
2022
Q1 | – | Sell |
-75
| Closed | -$4K | – | 1899 |
|
|
2021
Q4 | $4K | Buy |
+75
| New | +$3.88K | ﹤0.01% | 1652 |
|
|
2020
Q3 | – | Sell |
-46,634
| Closed | -$1.23M | – | 1527 |
|
|
2020
Q2 | $1.23M | Hold |
46,634
| – | – | ﹤0.01% | 666 |
|
|
2020
Q1 | $1.16M | Buy |
46,634
+8,200
| +21% | +$253K | ﹤0.01% | 567 |
|
|
2019
Q4 | $1.38M | Buy |
38,434
+2,834
| +8% | +$97.8K | ﹤0.01% | 673 |
|
|
2019
Q3 | $1.22M | Buy |
35,600
+8,000
| +29% | +$256K | ﹤0.01% | 652 |
|
|
2019
Q2 | $772K | Sell |
27,600
-14,600
| -35% | -$406K | ﹤0.01% | 767 |
|
|
2019
Q1 | $1.31M | Buy |
42,200
+11,700
| +38% | +$312K | 0.01% | 576 |
|
|
2018
Q4 | $721K | Buy |
30,500
+9,500
| +45% | +$259K | ﹤0.01% | 655 |
|
|
2018
Q3 | $814K | Buy |
21,000
+1,800
| +9% | +$64.9K | ﹤0.01% | 629 |
|
|
2018
Q2 | $643K | Buy |
19,200
+5,300
| +38% | +$189K | ﹤0.01% | 690 |
|
|
2018
Q1 | $504K | Buy |
+13,900
| New | +$481K | ﹤0.01% | 784 |
|
|
2017
Q4 | – | Sell |
-19,900
| Closed | -$745K | – | 1761 |
|
|
2017
Q3 | $745K | Sell |
19,900
-5,200
| -21% | -$177K | ﹤0.01% | 732 |
|
|
2017
Q2 | $784K | Sell |
25,100
-2,300
| -8% | -$66.4K | ﹤0.01% | 737 |
|
|
2017
Q1 | $675K | Hold |
27,400
| – | – | ﹤0.01% | 823 |
|
|
2016
Q4 | $694K | Buy |
27,400
+5,000
| +22% | +$111K | ﹤0.01% | 813 |
|
|
2016
Q3 | $444K | Buy |
+22,400
| New | +$391K | ﹤0.01% | 809 |
|
Other funds holding LMAT
CCA
CAM
CCM
Bessemer Group's LMAT Position: Q2 2026 in Review
Bessemer Group increased its LeMaitre Vascular (LMAT) stake by 28% in Q2 2026, buying an estimated $4.97M and bringing the position to 220,296 shares worth $21.1M. The position accounts for 0.03% of the portfolio, ranked #290.
Bessemer Group first reported a position in LMAT in Q3 2016 and has held it in 30 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Bessemer Group held 220,296 shares of LeMaitre Vascular worth $21.1M as of Q2 2026.
- Bessemer Group bought 48,458 LeMaitre Vascular shares in Q2 2026, an estimated $4.97M.
- LeMaitre Vascular made up 0.03% of Bessemer Group's portfolio in Q2 2026, its #290 holding.
- Bessemer Group first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 30 quarters since.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.